Nature de la demande
Réévaluation du SMR
Service Médical Rendu (SMR)
| Faible |
Le service médical rendu par MEGACE 160 mg est faible dans le traitement palliatif des carcinomes du sein.
|
eNq1mF1v2jAUhu/5FVHu80FLS5gC1cbaDanVGC3atBtkkgOYGTv1B6X79XMIXenkqK3BV1Fi5z0nPq8fHyW92KyItwYuMKNdvxnGvgc0Yzmm864/vrsKEv+i10iXaI32prXDOGye+F5GkBBdvxwNp4CoCH/eXH8G/T5wv9fwUjZdQiZfzFMSk/ArEosbVJRzvHTNcO6tQC5Y3vULJbdPvVRIrrPoPTD+WxQogzTaPdkfXU5a+8/TqBR7g6oSwK8RnRtFZ9xKM1OcA5V9JGHO+KNZOpucJO3zOE6sQmAxAsEUz2CI5GLI2RrnkJsjISLAKsjsIb8FviYgyyBG8WiZrYSVOFqizQjuB+akP+rRvtzIIA6a7fNm66zdjjutJLYKxfeWymwe/RFRNmmet5JOpxPNeLSCuXZaoC+g5zAS6Dup6xnkYFmvIeMSEUeVwqL/0nOO4nC4f9URORYFQY/hUhS2S4U40sPANRncfUj5BXdcs4roNftPnypCondmPd6RxFHGJaj6TFFZA5Srke1C9BmVsKmvqB0D5WbnRQzieLJ/GDXzf6imBGe2mNMgUnqjj0eDesq5BsQnJGDM3RHiB6Y5exDHJ89+pR1lX2zhaRQtJqfxWdI5tT/+f2lP1RxDl4qzAiINJCwO4cyAztihhNE2NUs9mdSpP7d9EssQgZpOKbAEkDbmU2PnzPrutlU1YBT9cnlna5nvCvjj7fbWKI3z7r9i29HZBfK1QV9LvNrH3cP2bCXyhu66lZye2Jmdm1mzkLIQH6JogUQgkF7CUO+0d50NF0dZAQ3d5wK6a/6dNAZVo1Qx11Hq0+okfXsJbffpa23Doa3w7v1dy22MIbmCA+pQId0ZeAeXx2f5cx/sLO3hC8K4C7PtWZHEjLrqm9TUqHjY6aHrSq+4hsO32QzX/I+p9WUaVf+Ceo00Kv8D9Rp/AVZsEE4=
mt2FQ1cx1WaBSASa